460 related articles for article (PubMed ID: 17411738)
1. Imaging to optimally stage lung cancer: conventional modalities and PET/CT.
Truong MT; Munden RF; Movsas B
J Am Coll Radiol; 2004 Dec; 1(12):957-64. PubMed ID: 17411738
[TBL] [Abstract][Full Text] [Related]
2. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
3. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients.
Ohno Y; Koyama H; Nogami M; Takenaka D; Yoshikawa T; Yoshimura M; Ohbayashi C; Sugimura K
J Magn Reson Imaging; 2007 Oct; 26(4):1071-80. PubMed ID: 17896365
[TBL] [Abstract][Full Text] [Related]
4. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.
Coleman RE; Delbeke D; Guiberteau MJ; Conti PS; Royal HD; Weinreb JC; Siegel BA; Federle MF; Townsend DW; Berland LL; ; ;
J Nucl Med; 2005 Jul; 46(7):1225-39. PubMed ID: 16000293
[TBL] [Abstract][Full Text] [Related]
5. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.
Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Xing L; Zhao D; Mu D; Sun X; Fang Y; Huang Y; Li W
Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978
[TBL] [Abstract][Full Text] [Related]
6. Can PET/CT replace separate diagnostic CT for cancer imaging? Optimizing CT protocols for imaging cancers of the chest and abdomen.
Kuehl H; Veit P; Rosenbaum SJ; Bockisch A; Antoch G
J Nucl Med; 2007 Jan; 48 Suppl 1():45S-57S. PubMed ID: 17204720
[TBL] [Abstract][Full Text] [Related]
7. Added value of PET and PET-CT in oesophageal cancer: a review of current practice.
Vinjamuri S; Ray S
Nucl Med Commun; 2008 Jan; 29(1):4-10. PubMed ID: 18049091
[TBL] [Abstract][Full Text] [Related]
8. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities.
Even-Sapir E
J Nucl Med; 2005 Aug; 46(8):1356-67. PubMed ID: 16085595
[TBL] [Abstract][Full Text] [Related]
9. Imaging in the diagnosis and treatment of non-small cell lung cancer.
Hicks RJ; Lau E; Alam NZ; Chen RY
Respirology; 2007 Mar; 12(2):165-72. PubMed ID: 17298447
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
[TBL] [Abstract][Full Text] [Related]
11. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
12. Current state of imaging for lung cancer staging.
Kent MS; Port JL; Altorki NK
Thorac Surg Clin; 2004 Feb; 14(1):1-13. PubMed ID: 15382304
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of lung cancer. Role of PET/CT fusion scan in lung cancer].
Melloni B; Gazaille V; Bertin F; Gaillard S; Monteil J
Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S11-16S16. PubMed ID: 17268330
[TBL] [Abstract][Full Text] [Related]
14. How do lung cancer specialists follow their patients with stage III non-small cell lung cancer (NSCLC) after definitive treatment? A short report.
Yumuk PF; Mohammed N; Maat AP; Fink C; Marchal B; O'Brien ME
Eur J Cancer; 2012 Sep; 48(14):2163-5. PubMed ID: 22633748
[TBL] [Abstract][Full Text] [Related]
15. The role of integrated positron emission tomography-computerized tomography in evaluating and staging patients with non-small cell lung cancer.
Cerfolio RJ; Bryant AS
Semin Thorac Cardiovasc Surg; 2007; 19(3):192-200. PubMed ID: 17983944
[TBL] [Abstract][Full Text] [Related]
16. Bilateral thoracoscopy, mediastinoscopy and laparoscopy, in addition to CT, MRI and PET imaging, are essential to correctly stage and treat patients with mesothelioma prior to trimodality therapy.
Alvarez JM; Hasani A; Segal A; Sterret G; Millward M; Nowak A; Musk W; Bydder S
ANZ J Surg; 2009 Oct; 79(10):734-8. PubMed ID: 19878170
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.
Tateishi U; Hosono A; Makimoto A; Nakamoto Y; Kaneta T; Fukuda H; Murakami K; Terauchi T; Suga T; Inoue T; Kim EE
Ann Nucl Med; 2009 Feb; 23(2):155-61. PubMed ID: 19225939
[TBL] [Abstract][Full Text] [Related]
18. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection.
Quaia E; Tona G; Gelain F; Lubin E; Pizzolato R; Boscolo E; Bussoli L
Acta Radiol; 2008 Nov; 49(9):995-1004. PubMed ID: 18651256
[TBL] [Abstract][Full Text] [Related]
19. Screening for cancer with PET and PET/CT: potential and limitations.
Schöder H; Gönen M
J Nucl Med; 2007 Jan; 48 Suppl 1():4S-18S. PubMed ID: 17204716
[TBL] [Abstract][Full Text] [Related]
20. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
Horger M; Bares R
Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
